Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information... Show more
FLGT is expected to report earnings to fall 272.41% to $1.00 per share on November 05
Q3'26
Est.
$1.00
Q2'26
Missed
by $0.14
Q1'26
Missed
by $0.25
Q4'25
Beat
by $0.22
Q3'25
Beat
by $0.36
The last earnings report on July 30 showed earnings per share of -57 cents, missing the estimate of -43 cents. With 120.92K shares outstanding, the current market capitalization sits at 553.06M.